CMS Open Payments · Program Year 2024
ulrich medical USA, Inc.
ulrich medical USA, Inc. reported $199,246.34 across General Payments, Research, and Ownership to 97 physicians and teaching hospitals across 97 transactions.
- $199.2K Below-median payer
- All-tracks total
- 97 Below-median volume
- Transactions
- 97 Below-median reach
- Recipients
- −$105.6K
- General Payments vs PY2023
ulrich medical USA, Inc. reported $199,246.34 across all CMS Open Payments tracks (General + Research + Ownership) to 97 physicians and teaching hospitals in Program Year 2024 - ranking #999 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $199,246.34, averaging $2.1K per recipient.
ulrich medical USA, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
12/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ulrich-medical-usa-inc ulrich medical USA, Inc.
$199.2K · #999/1,925 · 0.0% industry · PY2024
- TOT $199.2K
- RANK #999
- SHARE 0.0%
- TXN 97
- RCP 97
- CAT 4
- GEN $199.2K
- ΔGEN −$105.6K
- TOP1 28.0%
- PY 2024
Volume peers
Nearest volume peer: Applied Medical Technology Inc ($199.2K)
ulrich medical USA, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
ulrich medical USA, Inc.'s CMS-reported General Payments decreased by $105.6K (−34.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ULRICH MEDICAL USA, INC.PY2023: ULRICH MEDICAL USA, INC.PY2024: ulrich medical USA, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $304,857.58
- PY2024
- $199,246.34
What the Data Shows for ulrich medical USA, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For ulrich medical USA, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $114.1K, accounting for 57.2% of this company's General Payments and 5 transactions.
General Payment Breakdown by Type
Across 4 types of general payments, ulrich medical USA, Inc.'s largest category was "Royalty or License" at $114.1K - 57.2% of General Payments.
ulrich medical USA, Inc. reports 4 general-payment categories - the top three are Royalty or License (57.2%), Consulting Fee (36.5%), and Food and Beverage (3.3%). The remaining 1 category make up 2.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How ulrich medical USA, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $114.1K | 5 | 57.2% |
| Consulting Fee | $72.7K | 34 | 36.5% |
| Food and Beverage | $6.6K | 52 | 3.3% |
| Entertainment | $5.9K | 6 | 2.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $169,257.94 (84.9%) of $199,246.34 in this company's General Payments records across 50 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for ulrich medical USA, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Rhoderic Mirkin
$55,730.94 across 2 reported transactions
- 2
Steven Zeiller
$55,701.88 across 1 reported transactions
- 3
John Burleson
$24,161.01 across 5 reported transactions
- 4
Larry Parker
$20,173.65 across 2 reported transactions
- 5
Shaleen Vira
$13,490.46 across 17 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
ulrich medical USA, Inc.'s spend rank (#999 of 1,925, bottom 48% by spend) and concentration rank (#765 of 1,838, top 42% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Trice Medical, Inc. : $369.8K total payments, HHI 1959
- Dentsply Ih Ab : $186.8K total payments, HHI 1956
- G21 Srl : $9.2K total payments, HHI 1918
- R-Pharm US LLC : $588.45 total payments, HHI 1917
- Dmg America LLC : $176.1K total payments, HHI 1902
- United Imaging Healthcare North America, Inc. : $270.2K total payments, HHI 1892
- ulrich medical USA, Inc. (this company) : $199.2K total payments, HHI 1891
- NeuroOne Medical Technologies Corporation : $44.7K total payments, HHI 1889
- Eminent Spine, LLC : $35.3K total payments, HHI 1889
- SiVantage, Inc. : $3.8K total payments, HHI 1887
- Air Techniques, Inc. : $23.7K total payments, HHI 1886
- OnMark, Inc. : $93.7K total payments, HHI 1884
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as ulrich medical USA, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about ulrich medical USA, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with ulrich medical USA, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Noven Therapeutics, LLC
Emmaus Medical, Inc.
Pfizer International LLC
Celltrion, Inc.
Vifor (International) Ltd.
Put this to use
ulrich medical USA, Inc. ranks #999 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just ulrich medical USA, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.